VCNX OTC
Vaccinex, Inc.
1W: +4.1%
1M: +1.0%
3M: -9.8%
YTD: -10.6%
1Y: +62.9%
3Y: -93.6%
5Y: -99.8%
$1.01
+0.01 (+1.00%)
Weekly Expected Move ±22.3%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-04-01
Earliest Filing
2024-11-14
Latest Filing
investor: 5
partner: 1
Counterparties (Filed by VCNX)
6 relationshipsCompanies named in VCNX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| FCMI Parent Co. | — | investor | Purchased shares and pre-funded warrants in a private placement. | 2024-11-14 | View |
| Vaccinex (Rochester), L.L.C. | VCNX | investor | Purchased shares in a private placement. | 2024-11-14 | View |
| A.G.P./Alliance Global Partners | — | partner | Financial advisor for the Registered Direct Offering and Private Placement | 2024-04-01 | View |
| FCMI Parent Co. | — | investor | Private Placement Investor | 2024-04-01 | View |
| Vaccinex (Rochester), L.L.C. | VCNX | investor | Private Placement Investor | 2024-04-01 | View |
| Alzheimer's Drug Discovery Foundation | — | investor | Investor in Series A Preferred Stock and warrants | 2024-04-01 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2025-03-19 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-03-07 | Notice of Delisting or Transfer; Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-12-17 | Notice of Delisting or Transfer; Other Events; Financial Statements and Exhibits | View | |
| 2024-11-14 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2024-10-09 | Notice of Delisting or Transfer | View | |
| 2024-09-19 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2024-09-13 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-08-20 | Other Events | View | |
| 2024-08-14 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-07-31 | Other Events; Financial Statements and Exhibits | View | |
| 2024-06-06 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-05-09 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-04-12 | Notice of Delisting or Transfer | View | |
| 2024-04-01 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art | Agreement | View |
| 2024-03-28 | Other Events; Financial Statements and Exhibits | View | |
| 2024-03-04 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-02-21 | Other Events; Financial Statements and Exhibits | View | |
| 2024-02-15 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2024-02-08 | Financial Statements and Exhibits | View | |
| 2024-02-07 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR